These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15063929)

  • 41. Gene-expression signature of tumor recurrence in patients with stage II and III colon cancer treated with 5'fluoruracil-based adjuvant chemotherapy.
    Giráldez MD; Lozano JJ; Cuatrecasas M; Alonso-Espinaco V; Maurel J; Mármol M; Hörndler C; Ortego J; Alonso V; Escudero P; Ramírez G; Petry C; Lasalvia L; Bohmann K; Wirtz R; Mira A; Castells A
    Int J Cancer; 2013 Mar; 132(5):1090-7. PubMed ID: 22833293
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Adjuvant systemic chemo- or immunotherapy of colon cancer].
    Schlag PM
    Chirurg; 1994 Jun; 65(6):503-8. PubMed ID: 8088205
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Progress and challenges in the adjuvant treatment of stage II and III colon cancers.
    Chua YJ; Zalcberg JR
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):595-604. PubMed ID: 18402526
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Colon cancer: adjuvant chemotherapy and aftercare].
    Heinemann V; Giessen C; Modest D; Moosmann N; Stintzing S
    MMW Fortschr Med; 2011 Sep; 153(35):34-6. PubMed ID: 21916303
    [No Abstract]   [Full Text] [Related]  

  • 45. Adjuvant chemotherapy for stage II colon cancer: the time has come.
    Mamounas EP
    Eur J Surg Oncol; 2000 Dec; 26(8):725-9. PubMed ID: 11087634
    [No Abstract]   [Full Text] [Related]  

  • 46. Final results of randomized trials by the National Surgical Adjuvant Study of Colorectal Cancer (NSAS-CC).
    Hamaguchi T; Shirao K; Moriya Y; Yoshida S; Kodaira S; Ohashi Y;
    Cancer Chemother Pharmacol; 2011 Mar; 67(3):587-96. PubMed ID: 20490797
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adjuvant therapy for colon adenocarcinoma: current status of clinical investigation.
    Köhne-Wömpner CH; Schöffski P; Schmoll HJ
    Ann Oncol; 1994; 5 Suppl 3():97-104. PubMed ID: 8204538
    [TBL] [Abstract][Full Text] [Related]  

  • 48. FOLFOX4 in the adjuvant treatment of colon cancer in Asian patients.
    Lin YL; Liang JT
    Hepatogastroenterology; 2012; 59(114):400-4. PubMed ID: 22353506
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cetuximab plus FOLFOX-4 for fully resected stage III colon carcinoma: scientific background and the ongoing PETACC-8 trial.
    Taieb J; Puig PL; Bedenne L
    Expert Rev Anticancer Ther; 2008 Feb; 8(2):183-9. PubMed ID: 18279058
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Geographic variation and sociodemographic disparity in the use of oxaliplatin-containing chemotherapy in patients with stage III colon cancer.
    Panchal JM; Lairson DR; Chan W; Du XL
    Clin Colorectal Cancer; 2013 Jun; 12(2):113-21. PubMed ID: 23137529
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New adjuvant therapy for colon cancer: justified hope or commercial hype.
    Galanis E; Alberts SR; O'Connell MJ
    Surg Oncol Clin N Am; 2000 Oct; 9(4):813-23; discussion 825-6. PubMed ID: 11008249
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Results of chemotherapy in cancers of the colon].
    Seitz JF; Rougier P
    Bull Cancer; 1994 Apr; 81(4):260-76. PubMed ID: 7535602
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [II. Postoperative adjuvant chemotherapy for colon cancer. 2. Oxaliplatin combination does not help better treatment outcome].
    Shimada Y
    Gan To Kagaku Ryoho; 2012 Nov; 39(11):1646-9. PubMed ID: 23243702
    [No Abstract]   [Full Text] [Related]  

  • 54. Adjuvant chemotherapy for colon and rectal cancer.
    Fuchs CS; Mayer RJ
    Semin Oncol; 1995 Oct; 22(5):472-87. PubMed ID: 7570058
    [No Abstract]   [Full Text] [Related]  

  • 55. Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer.
    Moertel CG; Fleming TR; Macdonald JS; Haller DG; Laurie JA; Tangen CM; Ungerleider JS; Emerson WA; Tormey DC; Glick JH
    J Clin Oncol; 1995 Dec; 13(12):2936-43. PubMed ID: 8523058
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of 5-fluorouracil adjuvant treatment of colon cancer.
    Kelder W; Hospers GA; Plukker JT
    Expert Rev Anticancer Ther; 2006 May; 6(5):785-94. PubMed ID: 16759168
    [TBL] [Abstract][Full Text] [Related]  

  • 57. No clear evidence for adjuvant therapy in people with stage II colon cancer.
    Wille-Jørgensen P
    Cancer Treat Rev; 2005 Apr; 31(2):147-50. PubMed ID: 15847983
    [No Abstract]   [Full Text] [Related]  

  • 58. CAPOX associated with toxicities of higher grade but improved disease-free survival when compared with FOLFOX in the adjuvant treatment of stage III colon cancer.
    Loree JM; Mulder KE; Ghosh S; Spratlin JL
    Clin Colorectal Cancer; 2014 Sep; 13(3):172-7. PubMed ID: 24630275
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Timeliness of adjuvant chemotherapy for stage III adenocarcinoma of the colon: a measure of quality of care.
    Yu S; Shabihkhani M; Yang D; Thara E; Senagore A; Lenz HJ; Sadeghi S; Barzi A
    Clin Colorectal Cancer; 2013 Dec; 12(4):275-9. PubMed ID: 24188686
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer.
    O'Connell MJ; Laurie JA; Kahn M; Fitzgibbons RJ; Erlichman C; Shepherd L; Moertel CG; Kocha WI; Pazdur R; Wieand HS; Rubin J; Vukov AM; Donohue JH; Krook JE; Figueredo A
    J Clin Oncol; 1998 Jan; 16(1):295-300. PubMed ID: 9440756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.